Travis C. Mickle - 25 May 2022 Form 4 Insider Report for KEMPHARM, INC (ZVRA)

Role
President & CEO, Director
Signature
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for Travis C. Mickle
Issuer symbol
ZVRA
Transactions as of
25 May 2022
Net transactions value
+$56,996
Form type
4
Filing time
25 May 2022, 21:03:57 UTC
Previous filing
03 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZVRA Common Stock Purchase $8,711 +2,000 +5.5% $4.36 38,521 25 May 2022 Direct
transaction ZVRA Common Stock Purchase $4,385 +1,000 +2.6% $4.38 39,521 25 May 2022 Direct
transaction ZVRA Common Stock Purchase $43,900 +10,000 +967% $4.39 11,034 25 May 2022 By Mickle Investments LLC F1
holding ZVRA Common Stock 15,242 25 May 2022 By Christal M.M. Mickle 2015 Gift Trust dtd 7/21/15, as trustee
holding ZVRA Common Stock 9,824 25 May 2022 By Travis C. Mickle 2015 Dynasty Trust dtd 7/21/15, Christal M.M. Mickle as trustee
holding ZVRA Common Stock 96,153 25 May 2022 By Mickle Holdings LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is the sole manager member of Mickle Investments, LLC.
F2 The Reporting Person is the sole manager member of Mickle Holdings, LLC.